Items where Author is "Gribben, John G."

Up a level
Export as [feed] Atom [feed] RSS
Group by: Item Type | Full Text | No Grouping
Number of items: 2.

file
EDELMANN, Jennifer, DOKAL, Arran D., VILVENTHRARAJA, Emma, HOLZMANN, Karlheinz, BRITTON, David, KLYMENKO, Tetyana, DÖHNER, Hartmut, CRAGG, Mark, BRAUN, Andrejs, CUTILLAS, Pedro and GRIBBEN, John G. (2021). Rituximab and obinutuzumab differentially hijack the B-cell receptor and NOTCH1 signaling pathways. iScience, 24 (2), p. 102089.

BLOEHDORN, Johannes, BRAUN, Andrejs, JEBARAJ, Billy Michael Chelliah, TAYLOR-WEINER, Amaro, ROBRECHT, Sandra, KRZYKALLA, Julia, HOLZMANN, Karlheinz, JOHNSTON, Harvey, KLYMENKO, Tetyana, EICHHORST, Barbara, YEH, Ru-Fang, WEISSER, Martin, EDELMANN, Jennifer, FISCHER, Kirsten, GRIBBEN, John G., LANDAU, Dan A., NEUBERG, Donna S., CRAGG, Mark S, BENNER, Axel, HALLEK, Michael, WU, Catherine J., DÖHNER, Hartmut, STILGENBAUER, Stephan and MERTENS, Daniel (2020). Multiplatform Profiling Characterizes Functional Networks in Genomically Stable and Instable Chronic Lymphocytic Leukemia [abstract only]. Blood, 136, 12-13.

This list was generated on Wed May 1 02:33:53 2024 UTC.